Skip to main content
Top
Literature
1.
go back to reference Jonas JB, Akkoyun I, Kreissig I, Degenring RF (2005) Diffuse diabetic macular edema treated by intravitreal triamcinolone acetonide. A comparative non-randomised study. Br J Ophthalmol 89:321–326PubMedCrossRef Jonas JB, Akkoyun I, Kreissig I, Degenring RF (2005) Diffuse diabetic macular edema treated by intravitreal triamcinolone acetonide. A comparative non-randomised study. Br J Ophthalmol 89:321–326PubMedCrossRef
2.
go back to reference Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I (2005) Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative non-randomized study. Eye 19:163–170PubMedCrossRef Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I (2005) Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative non-randomized study. Eye 19:163–170PubMedCrossRef
3.
go back to reference Haller JA, Bandello F, Jr Belfort R, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, OZURDEX GENEVA Study Group (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134.e3–1146.e3CrossRef Haller JA, Bandello F, Jr Belfort R, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, OZURDEX GENEVA Study Group (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134.e3–1146.e3CrossRef
4.
go back to reference Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, Welty D (2011) Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 52:80–86PubMedCrossRef Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, Welty D (2011) Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 52:80–86PubMedCrossRef
5.
go back to reference Lowder C, Jr Belfort R, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM, Ozurdex HURON Study Group (2011) Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129:545–553PubMedCrossRef Lowder C, Jr Belfort R, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM, Ozurdex HURON Study Group (2011) Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129:545–553PubMedCrossRef
6.
go back to reference Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY, Liu CC, Lou J, Whitcup SM, Ozurdex CHAMPLAIN Study Group (2011) Dexamethasone intravitreal implant for treatment of macular edema in vitrectomized patients. Retina 31:915–923PubMedCrossRef Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY, Liu CC, Lou J, Whitcup SM, Ozurdex CHAMPLAIN Study Group (2011) Dexamethasone intravitreal implant for treatment of macular edema in vitrectomized patients. Retina 31:915–923PubMedCrossRef
Metadata
Title
Steroid implant in anterior chamber of an aphakic vitrectomized eye
Authors
Jost B. Jonas
Matthias Schmidbauer
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 1/2013
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-011-1839-x

Other articles of this Issue 1/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2013 Go to the issue